{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:57:58Z","timestamp":1794013078189,"version":"4.8.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00109-011-0834-3","type":"journal-article","created":{"date-parts":[[2011,11,21]],"date-time":"2011-11-21T11:18:25Z","timestamp":1321874305000},"page":"575-585","source":"Crossref","is-referenced-by-count":94,"title":["Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity"],"prefix":"10.1007","volume":"90","author":[{"given":"Shi-Bing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Matthew","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Chi","family":"Tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Rowson-Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Yu","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuh Nung","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily Yeh","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,22]]},"reference":[{"key":"834_CR1","doi-asserted-by":"crossref","first-page":"30697","DOI":"10.1074\/jbc.M505553200","volume":"280","author":"S Wullschleger","year":"2005","unstructured":"Wullschleger S, Loewith R, Oppliger W, Hall MN (2005) Molecular organization of target of rapamycin complex 2. J Biol Chem 280:30697\u201330704","journal-title":"J Biol Chem"},{"key":"834_CR2","doi-asserted-by":"crossref","first-page":"E581","DOI":"10.1152\/ajpendo.90437.2008","volume":"296","author":"S Boura-Halfon","year":"2009","unstructured":"Boura-Halfon S, Zick Y (2009) Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab 296:E581\u2013E591","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"834_CR3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drudis.2006.12.008","volume":"12","author":"CK Tsang","year":"2007","unstructured":"Tsang CK, Qi H, Liu LF, Zheng XF (2007) Targeting mammalian target of rapamycin (mTOR) for health and diseases. Drug Discov Today 12:112\u2013124","journal-title":"Drug Discov Today"},{"key":"834_CR4","doi-asserted-by":"crossref","first-page":"e9979","DOI":"10.1371\/journal.pone.0009979","volume":"5","author":"P Spilman","year":"2010","unstructured":"Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, Richardson A, Strong R, Galvan V (2010) Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer\u2019s disease. PLoS One 5:e9979","journal-title":"PLoS One"},{"key":"834_CR5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature08221","volume":"460","author":"DE Harrison","year":"2009","unstructured":"Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS et al (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460:392\u2013395","journal-title":"Nature"},{"key":"834_CR6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/gerona\/glq117","volume":"65","author":"D Hamerman","year":"2010","unstructured":"Hamerman D (2010) Can biogerontologists and geriatricians unite to apply aging science to health care in the decade ahead? J Gerontol A Biol Sci Med Sci 65:1193\u20131197","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"834_CR7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1098\/rstb.2010.0198","volume":"366","author":"MA McCormick","year":"2011","unstructured":"McCormick MA, Tsai SY, Kennedy BK (2011) TOR and ageing: a complex pathway for a complex process. Philos Trans R Soc Lond B Biol Sci 366:17\u201327","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"Suppl","key":"834_CR8","first-page":"S3","volume":"40","author":"KG Alberti","year":"1998","unstructured":"Alberti KG (1998) Impaired glucose tolerance: what are the clinical implications? Diabetes Res Clin Pract 40(Suppl):S3\u2013S8","journal-title":"Diabetes Res Clin Pract"},{"key":"834_CR9","doi-asserted-by":"crossref","first-page":"16H","DOI":"10.1016\/S0002-9149(01)01832-X","volume":"88","author":"AD Baron","year":"2001","unstructured":"Baron AD (2001) Impaired glucose tolerance as a disease. Am J Cardiol 88:16H\u201319H","journal-title":"Am J Cardiol"},{"key":"834_CR10","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0895-4356(97)00119-4","volume":"50","author":"G Nijpels","year":"1997","unstructured":"Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heine RJ (1997) Cardiovascular risk factors prior to the development of non-insulin-dependent diabetes mellitus in persons with impaired glucose tolerance: the Hoorn Study. J Clin Epidemiol 50:1003\u20131009","journal-title":"J Clin Epidemiol"},{"key":"834_CR11","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2337\/diacare.25.10.1845","volume":"25","author":"JB Meigs","year":"2002","unstructured":"Meigs JB, Nathan DM, D\u2019Agostino RB Sr, Wilson PW (2002) Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 25:1845\u20131850","journal-title":"Diabetes Care"},{"key":"834_CR12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neubiorev.2008.10.008","volume":"33","author":"DJ Lamport","year":"2009","unstructured":"Lamport DJ, Lawton CL, Mansfield MW, Dye L (2009) Impairments in glucose tolerance can have a negative impact on cognitive function: a systematic research review. Neurosci Biobehav Rev 33:394\u2013413","journal-title":"Neurosci Biobehav Rev"},{"key":"834_CR13","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.cub.2004.08.026","volume":"14","author":"OJ Shah","year":"2004","unstructured":"Shah OJ, Wang Z, Hunter T (2004) Inappropriate activation of the TSC\/Rheb\/mTOR\/S6K cassette induces IRS1\/2 depletion, insulin resistance, and cell survival deficiencies. Curr Biol 14:1650\u20131656","journal-title":"Curr Biol"},{"key":"834_CR14","first-page":"633","volume":"22","author":"DF Lee","year":"2008","unstructured":"Lee DF, Kuo HP, Chen CT, Wei Y, Chou CK, Hung JY, Yen CJ, Hung MC (2008) IKKbeta suppression of TSC1 function links the mTOR pathway with insulin resistance. Int J Mol Med 22:633\u2013638","journal-title":"Int J Mol Med"},{"key":"834_CR15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2006.05.003","volume":"3","author":"SH Um","year":"2006","unstructured":"Um SH, D\u2019Alessio D, Thomas G (2006) Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab 3:393\u2013402","journal-title":"Cell Metab"},{"key":"834_CR16","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1681\/ASN.2007111202","volume":"19","author":"O Johnston","year":"2008","unstructured":"Johnston O, Rose CL, Webster AC, Gill JS (2008) Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am Soc Nephrol 19:1411\u20131418","journal-title":"J Am Soc Nephrol"},{"key":"834_CR17","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2337\/db07-0922","volume":"57","author":"M Fraenkel","year":"2008","unstructured":"Fraenkel M, Ketzinel-Gilad M, Ariav Y, Pappo O, Karaca M, Castel J, Berthault MF, Magnan C, Cerasi E, Kaiser N et al (2008) mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes. Diabetes 57:945\u2013957","journal-title":"Diabetes"},{"key":"834_CR18","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2337\/db09-1324","volume":"59","author":"VP Houde","year":"2010","unstructured":"Houde VP, Brule S, Festuccia WT, Blanchard PG, Bellmann K, Deshaies Y, Marette A (2010) Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Diabetes 59:1338\u20131348","journal-title":"Diabetes"},{"key":"834_CR19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1742-7843.2009.00427.x","volume":"105","author":"GR Chang","year":"2009","unstructured":"Chang GR, Wu YY, Chiu YS, Chen WY, Liao JW, Hsu HM, Chao TH, Hung SW, Mao FC (2009) Long-term administration of rapamycin reduces adiposity, but impairs glucose tolerance in high-fat diet-fed KK\/HlJ mice. Basic Clin Pharmacol Toxicol 105:188\u2013198","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"834_CR20","doi-asserted-by":"crossref","first-page":"E1323","DOI":"10.1152\/ajpendo.90617.2008","volume":"295","author":"S Andrikopoulos","year":"2008","unstructured":"Andrikopoulos S, Blair AR, Deluca N, Fam BC, Proietto J (2008) Evaluating the glucose tolerance test in mice. Am J Physiol Endocrinol Metab 295:E1323\u2013E1332","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"834_CR21","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1097\/01.TP.0000068871.09469.E0","volume":"75","author":"T Sawada","year":"2003","unstructured":"Sawada T, Matsumoto I, Nakano M, Kirchhof N, Sutherland DE, Hering BJ (2003) Improved islet yield and function with ductal injection of University of Wisconsin solution before pancreas preservation. Transplantation 75:1965\u20131969","journal-title":"Transplantation"},{"key":"834_CR22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00424-003-1097-9","volume":"446","author":"S Speier","year":"2003","unstructured":"Speier S, Rupnik M (2003) A novel approach to in situ characterization of pancreatic beta-cells. Pflugers Arch 446:553\u2013558","journal-title":"Pflugers Arch"},{"key":"834_CR23","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/j.1582-4934.2007.00169.x","volume":"12","author":"HY Lee","year":"2008","unstructured":"Lee HY, Yea K, Kim J, Lee BD, Chae YC, Kim HS, Lee DW, Kim SH, Cho JH, Jin CJ et al (2008) Epidermal growth factor increases insulin secretion and lowers blood glucose in diabetic mice. J Cell Mol Med 12:1593\u20131604","journal-title":"J Cell Mol Med"},{"key":"834_CR24","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.2337\/diabetes.54.9.2557","volume":"54","author":"M Teta","year":"2005","unstructured":"Teta M, Long SY, Wartschow LM, Rankin MM, Kushner JA (2005) Very slow turnover of beta-cells in aged adult mice. Diabetes 54:2557\u20132567","journal-title":"Diabetes"},{"key":"834_CR25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1523-1755.2001.00460.x","volume":"59","author":"RN Saunders","year":"2001","unstructured":"Saunders RN, Metcalfe MS, Nicholson ML (2001) Rapamycin in transplantation: a review of the evidence. Kidney Int 59:3\u201316","journal-title":"Kidney Int"},{"key":"834_CR26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0079-6107(89)90013-8","volume":"54","author":"FM Ashcroft","year":"1989","unstructured":"Ashcroft FM, Rorsman P (1989) Electrophysiology of the pancreatic beta-cell. Prog Biophys Mol Biol 54:87\u2013143","journal-title":"Prog Biophys Mol Biol"},{"key":"834_CR27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1749-6632.2008.04003.x","volume":"1152","author":"A Rozzo","year":"2009","unstructured":"Rozzo A, Meneghel-Rozzo T, Delakorda SL, Yang SB, Rupnik M (2009) Exocytosis of insulin: in vivo maturation of mouse endocrine pancreas. Ann N Y Acad Sci 1152:53\u201362","journal-title":"Ann N Y Acad Sci"},{"key":"834_CR28","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.transproceed.2008.02.011","volume":"40","author":"E Zahr","year":"2008","unstructured":"Zahr E, Molano RD, Pileggi A, Ichii H, San Jose S, Bocca N, An W, Gonzalez-Quintana J, Fraker C, Ricordi C et al (2008) Rapamycin impairs beta-cell proliferation in vivo. Transplant Proc 40:436\u2013437","journal-title":"Transplant Proc"},{"key":"834_CR29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.molmed.2007.04.002","volume":"13","author":"SG Dann","year":"2007","unstructured":"Dann SG, Selvaraj A, Thomas G (2007) mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med 13:252\u2013259","journal-title":"Trends Mol Med"},{"key":"834_CR30","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1083\/jcb.200408161","volume":"167","author":"BD Manning","year":"2004","unstructured":"Manning BD (2004) Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J Cell Biol 167:399\u2013403","journal-title":"J Cell Biol"},{"key":"834_CR31","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0304-4165(65)90196-0","volume":"107","author":"SR Wagle","year":"1965","unstructured":"Wagle SR (1965) Studies on biosynthesis and catabolism of insulin. Biochim Biophys Acta 107:524\u2013530","journal-title":"Biochim Biophys Acta"},{"key":"834_CR32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02171742","volume":"2","author":"M Wood","year":"1994","unstructured":"Wood M, Bierer B (1994) Rapamycin: biological and therapeutic effects, binding by immunophilins and molecular targets of action. Perspect Drug Discov Des 2:163\u2013184","journal-title":"Perspect Drug Discov Des"},{"key":"834_CR33","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1172\/JCI32959","volume":"117","author":"T Nir","year":"2007","unstructured":"Nir T, Melton DA, Dor Y (2007) Recovery from diabetes in mice by beta cell regeneration. J Clin Invest 117:2553\u20132561","journal-title":"J Clin Invest"},{"key":"834_CR34","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.2337\/db06-1016","volume":"56","author":"M Krebs","year":"2007","unstructured":"Krebs M, Brunmair B, Brehm A, Artwohl M, Szendroedi J, Nowotny P, Roth E, Furnsinn C, Promintzer M, Anderwald C et al (2007) The mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man. Diabetes 56:1600\u20131607","journal-title":"Diabetes"},{"key":"834_CR35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2249.1992.tb06928.x","volume":"89","author":"WL Baeder","year":"1992","unstructured":"Baeder WL, Sredy J, Sehgal SN, Chang JY, Adams LM (1992) Rapamycin prevents the onset of insulin-dependent diabetes mellitus (IDDM) in NOD mice. Clin Exp Immunol 89:174\u2013178","journal-title":"Clin Exp Immunol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00109-011-0834-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T21:52:10Z","timestamp":1560981130000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-011-0834-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,22]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["834"],"URL":"https:\/\/doi.org\/10.1007\/s00109-011-0834-3","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,22]]}}}